rs2393618

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_020987.5(ANK3):​c.2478+1794C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0291 in 152,290 control chromosomes in the GnomAD database, including 179 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.029 ( 179 hom., cov: 32)

Consequence

ANK3
NM_020987.5 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -0.0950

Publications

1 publications found
Variant links:
Genes affected
ANK3 (HGNC:494): (ankyrin 3) Ankyrins are a family of proteins that are believed to link the integral membrane proteins to the underlying spectrin-actin cytoskeleton and play key roles in activities such as cell motility, activation, proliferation, contact, and the maintenance of specialized membrane domains. Multiple isoforms of ankyrin with different affinities for various target proteins are expressed in a tissue-specific, developmentally regulated manner. Most ankyrins are typically composed of three structural domains: an amino-terminal domain containing multiple ankyrin repeats; a central region with a highly conserved spectrin binding domain; and a carboxy-terminal regulatory domain which is the least conserved and subject to variation. Ankyrin 3 is an immunologically distinct gene product from ankyrins 1 and 2, and was originally found at the axonal initial segment and nodes of Ranvier of neurons in the central and peripheral nervous systems. Multiple transcript variants encoding different isoforms have been found for this gene.[provided by RefSeq, Feb 2011]
ANK3 Gene-Disease associations (from GenCC):
  • intellectual disability-hypotonia-spasticity-sleep disorder syndrome
    Inheritance: AR Classification: STRONG, SUPPORTIVE, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), Orphanet, Ambry Genetics
  • intellectual disability
    Inheritance: AR, AD Classification: MODERATE, LIMITED Submitted by: ClinGen, Ambry Genetics
  • Tourette syndrome
    Inheritance: Unknown Classification: LIMITED Submitted by: Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.83).
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.0821 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_020987.5. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
ANK3
NM_020987.5
MANE Select
c.2478+1794C>T
intron
N/ANP_066267.2
ANK3
NM_001204404.2
c.2427+1794C>T
intron
N/ANP_001191333.1
ANK3
NM_001320874.2
c.2478+1794C>T
intron
N/ANP_001307803.1

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
ANK3
ENST00000280772.7
TSL:1 MANE Select
c.2478+1794C>T
intron
N/AENSP00000280772.1
ANK3
ENST00000373827.6
TSL:1
c.2460+1794C>T
intron
N/AENSP00000362933.2
ANK3
ENST00000503366.6
TSL:2
c.2427+1794C>T
intron
N/AENSP00000425236.1

Frequencies

GnomAD3 genomes
AF:
0.0291
AC:
4421
AN:
152172
Hom.:
177
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0842
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0160
Gnomad ASJ
AF:
0.00720
Gnomad EAS
AF:
0.0728
Gnomad SAS
AF:
0.0226
Gnomad FIN
AF:
0.00104
Gnomad MID
AF:
0.00949
Gnomad NFE
AF:
0.00175
Gnomad OTH
AF:
0.0201
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.0291
AC:
4438
AN:
152290
Hom.:
179
Cov.:
32
AF XY:
0.0284
AC XY:
2118
AN XY:
74472
show subpopulations
African (AFR)
AF:
0.0844
AC:
3508
AN:
41548
American (AMR)
AF:
0.0159
AC:
244
AN:
15300
Ashkenazi Jewish (ASJ)
AF:
0.00720
AC:
25
AN:
3470
East Asian (EAS)
AF:
0.0731
AC:
379
AN:
5182
South Asian (SAS)
AF:
0.0222
AC:
107
AN:
4826
European-Finnish (FIN)
AF:
0.00104
AC:
11
AN:
10618
Middle Eastern (MID)
AF:
0.0102
AC:
3
AN:
294
European-Non Finnish (NFE)
AF:
0.00175
AC:
119
AN:
68032
Other (OTH)
AF:
0.0199
AC:
42
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
216
432
648
864
1080
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
50
100
150
200
250
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0126
Hom.:
30
Bravo
AF:
0.0328
Asia WGS
AF:
0.0470
AC:
165
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.83
CADD
Benign
1.5
DANN
Benign
0.64
PhyloP100
-0.095
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2393618; hg19: chr10-61930272; API